CC-1088
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CC-1088, covering 2017-04-25 to 2017-04-25. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndromes [Phase 2]